| Section | Status | CDF | Name |
| 08.03.04.02 | Restricted Use |  |
Abiraterone Actetate Zytiga® |
| 08.02 | Formulary | |
Acalabrutinib Calquence® |
| 08.02.03 | Restricted Use | |
Atezolizumab Tecentriq® |
| 08.02.03 | Restricted Use | |
Brentuximab vedotin Adcetris® |
| 08.02 | Formulary | |
Brigatinib Alunbrig® |
| 08.02.03 | Formulary | |
Daratumumab Darzalex® |
| 08.02.03 | Restricted Use | |
Durvalumab Imfinzi® |
| 08.03.04.02 | Restricted Use | |
Enzalutamide Xtandi® |
| 08.02.03 | Restricted Use | |
Isatuximab Sarclisa® |
| 08.01 | Non Formulary | |
Lorlatinib Lorviqua® |
| 08.02 | Formulary | |
Lorlatinib Lorviqua® |
| 08.02 | Formulary | |
Niraparib Zejula® |
| 08.02 | Formulary | |
Osimertinib Tagrisso® |
| 08.02 | Formulary | |
Rucaparib Rubraca® |
| 08.02 | Formulary | |
Venetoclax Venclyxto® |